What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

EFPIA signs joint declaration championing open trade in the EU.

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

The highlights of the trade show and its conference agenda - day 3

The highlights of the trade show and its conference agenda - day 2

The highlights of the trade show and its conference agenda - day 1